Back
Zenas BioPharma Vs. Bicara Therapeutics Industry Stock Comparison
Sell
12
ZBIO
Zenas BioPharma
Last Price:
9.06
Seasonality Move:
-5.65%
Sell
25
BCAX
Bicara Therapeutics
Last Price:
18.70
Seasonality Move:
--
Sell
12
Zenas BioPharma (ZBIO)
is a Sell
Is Zenas BioPharma a Buy, Sell or Hold?
- The current Zenas BioPharma [ZBIO] share price is $9.16. The Score for ZBIO is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
- ZBIO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
25
Bicara Therapeutics (BCAX)
is a Sell
Is Bicara Therapeutics a Buy, Sell or Hold?
- The current Bicara Therapeutics [BCAX] share price is $19.92. The Score for BCAX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- BCAX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ZBIO Stock Price Chart
What is Zenas BioPharma's stock price today?
-
The Zenas BioPharma share price today is $9.16
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZBIO is experiencing selling pressure, which indicates risk of future bearish movement.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $19.92
The current trend is moderately bearish and BCAX is experiencing slight buying pressure.
ZBIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.23 | Sell |
Relative Strength Index (14 RSI): | 26.96 | Sell |
Chaikin Money Flow: | -179556 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.78 - 18.38) | Sell |
Bollinger Bands (100): | (8.91 - 18.69) | Sell |
BCAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 46.35 | Sell |
Chaikin Money Flow: | 135867 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.78 - 22.44) | Sell |
Bollinger Bands (100): | ( - ) | Buy |
ZBIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.23 | Sell |
20-day SMA: | 12.37 | Sell |
50-day SMA: | 17.1 | Sell |
200-day SMA: | 12.9 | Sell |
8-day EMA: | 10.28 | Sell |
20-day EMA: | 12.4 | Sell |
50-day EMA: | 14.48 | Sell |
200-day EMA: | 13.82 | Sell |
BCAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.02 | Sell |
20-day SMA: | 19.89 | Buy |
50-day SMA: | 21.6 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 20.06 | Sell |
20-day EMA: | 20.26 | Sell |
50-day EMA: | 18.43 | Buy |
200-day EMA: | 8.75 | Buy |
Zenas BioPharma Earnings Growth & ZBIO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $2.89 per share.
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.26 per share.
Zenas BioPharma Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bicara Therapeutics Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |